01557nam 2200409z- 450 991069434480332120080910092237.0(CKB)5860000000030788(BIP)015768141(EXLCZ)99586000000003078820220406c2007uuuu -u- -engPatient safety and quality issues in end stage renal disease treatment hearing before the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, second session, December 6, 20061 online resource (iii, 94 p.) ill0-16-078967-2 Patient safety and quality issues in end stage renal disease treatment Chronic renal failureTreatmentUnited StatesChronic renal failureGovernment policyUnited StatesMedicareQuality controlDrugsPricesUnited StatesPharmaceutical services insuranceUnited StatesMedical careChronic renal failureDrugsHealth insuranceLawMedicalBusiness & economicsChronic renal failureTreatmentChronic renal failureGovernment policyMedicareQuality control.DrugsPricesPharmaceutical services insuranceBOOK9910694344803321Patient safety and quality issues in end stage renal disease treatment3133460UNINA